IBSA DERMA EXPANDS TO BRAZIL TO INTRODUCE “AUTHENTIC BEAUTY”.04 May 2022
PEOPLE AS THE MAIN DRIVER OF IBSA’S GROWTH
At the 32nd Congresso Brasileiro de Cirurgia Dermatológica in Recife, organized by SBCD (Sociedade Brasileira de Cirurgia Dermatologica) IBSA Derma launched the Profhilo® product line in Brazil, one of the most important international markets and of greatest potential.
Access to this market, after the success achieved in the UK, UAE and Singapore, represents for IBSA a great opportunity to promote the model of authentic beauty which makes us unique and irreplaceable.
Throughout the tour, which touched the cities of Recife, Rio de Janeiro and Sao Paulo, IBSA presented to medical professionals and to the hundreds of scientific and commercial partners, its innovation and technologies. In particular, the patented NAHYCO® technology, which has become a world-renowned landmark for bio-remodeling cutaneous laxity of the face and body.
“Brazil represents a fundamental step in the process of IBSA’s international expansion” – says Tania Pirazzini, Head of Dermoaesthetic Department. “A step which confirms the strategic and successful strategy of enhancing authentic beauty coming from within and spreading through the skin”.
The brand enters, in fact, the second world market for aesthetic medicine thanks to the partnership signed with local distributor POL-LUX Brazil, giving support to clinics and local KOLs with tailored trainings and workshops.
“Behind IBSA’s success – explains Luca Crippa, IBSA Farmaceutici’s CEO & Managing Director – is the innovative vision, the investments in Research and Development and the talent of the People who allow us to bring our know-how and the excellence of Made in Italy abroad”.